Bliss GVS Pharma Limited notified that the Company has received an order dated May 17, 2024, from the Office of the Joint Commissioner, Food and Drugs Administration which was provided in person to the Company's official on June 19, 2024. Name of the authority; Office of the Joint Commissioner (Konkan Division), Food and Drugs Administration. Order for suspension of FDA license issued to Company's Tablet division of manufacturing unit located at Plot No.

10, 11A & 12, Dewan & Sons Udyog Nagar, Aliyali Village, Palghar (West), for a period of 5 days in the month of August 2024 i.e. from August 18, 2024 to August 20, 2024 for violation of provisions under Drugs and Cosmetics Act, 1940 and rules made thereunder. Not in agreement with the FDA rulings, being the basis for the said suspension, the Company is in the process of evaluating option and procedure for appealing against the said order with the State Government. The Company received an order dated May 17, 2024, which was provided in person to the Company's official on dated June 19, 2024.

The order was issued in vernacular language and due to which there was a delay in the interpretation and dissemination of information within the prescribed timelines.